Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Here's the second talk from our recent webinar, partnering with LUNGevity Foundation to cover the ASCO Highlights in Lung Cancer, and this talk followed after the presentation by Dr. Mary Pinder on highlights in SCLC, early stage NSCLC, and mesothelioma and covered developments in advanced NSCLC. Dr. Nasser Hanna, an international leader in the field from Indiana University, summarized the most important new data in this arena.
Below you'll find links to the audio and video versions of the podcast, as well as the transcript and figures from his talk.
[powerpress]
hanna-asco-2011-highlights-advanced-nsclc-audio-podcast
hanna-asco-2011-highlights-advanced-nsclc-transcript
hanna-asco-2011-highlights-advanced-nsclc-figures
The third and final podcast in this series will be the question and answer session, which will be out shortly.
As always, we welcome your questions and comments here. On behalf of GRACE and LUNGevity Foundation, we hope you find this webinar content helpful.
Please feel free to offer comments and raise questions in our
discussion forums.
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.